Bioequivalence Study for Acarbose / Metformin FDC

Inclusion Criteria: * Body Mass Index (BMI): 18 to 28 kg/m2 (inclusive) * Results of Glycosylated Hemoglobin A1c (HbA1c) value are within the normal range (4.3-5.6%, inclusive) * Results of the 75 g oral glucose tolerance test (OGTT) during screening show: * Blood glucose before OGTT \<110 mg/dL. * Blood glucose 1 hour after glucose loading \<180 mg/dL * Blood glucose 2 hours after glucose loading \<140 mg/dL Exclusion Criteria: * A history of relevant diseases of internal organs (diabetes mellitus, Ileus, Ileus-like symptoms, diseases that may significantly jeopardize body systems * Febrile illness within 1 week before drug administration * Family history of diabetes (within the second degree of relationship) * Known drug hypersensitivity or idiosyncrasy * Known severe allergies, non-allergic drug reactions, or multiple drug allergies * Habitual medication including Chinese herbal drugs * Intake of any drugs within 2 weeks of drug administration of period 1 * Regular daily consumption of more than 1 L of usual beer or the equivalent quantity of approximately 40 g of alcohol in another form * Donation of more than 150 mL of blood within 4 weeks before the screening examination * Participation in another clinical trial within 4 weeks before the screening examination